Targeted resequencing of candidate genes reveals novel variants associated with severe Behçet's uveitis

Experimental and Molecular Medicine

Volumn 45, Issue 10, 2013, Pages

  Kim, Sang Jin ^a,b   Lee, Seungbok ^a,c   Park, Changho ^a   Seo, Jeong Sun ^a,c,d   Kim, Jong Il ^a,c,e   Yu, Hyeong Gon ^a  

^a Seoul National University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d Macrogen Inc   (South Korea)

^e Psoma Therapeutics   (South Korea)

Author keywords

Beh et's disease; next generation sequencing; uveitis

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; ALPHA INTERFERON; FC RECEPTOR; FCGR3A PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; ICAM1 PROTEIN, HUMAN; IFNA1 PROTEIN, HUMAN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL4; KIR2DL4 PROTEIN, HUMAN; KIR3DL3 PROTEIN, HUMAN; MHC CLASS I-RELATED CHAIN A; MHC CLASS I RELATED CHAIN A;

ADULT; ARTICLE; BEHCET DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; EXON; FCGR3A GENE; FEMALE; GENE; GENE FREQUENCY; GENE FUNCTION; GENE LOCUS; GENE REPLICATION; GENE SEQUENCE; GENE TARGETING; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; ICAM1 GENE; IFNAR1 GENE; KIR3DL3 GENE; KIR3DL4 GENE; MAJOR CLINICAL STUDY; MALE; MICA GENE; MIDDLE AGED; MTFHR GENE; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; UVEITIS; AGED; CASE CONTROL STUDY; GENETICS;

ADULT; AGED; BEHCET SYNDROME; CASE-CONTROL STUDIES; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON-ALPHA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IGG; RECEPTORS, KIR; RECEPTORS, KIR2DL4;

EID: 84892393013     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2013.101     Document Type: Article

References (40)

1. Deuter CM, Kotter I, Wallace GR, Murray PI, Stubiger N, Zierhut M. Behcet's disease: ocular effects and treatment. Prog Retin Eye Res 2008; 27: 111-136.
2. Direskeneli H. Behcet's disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis 2001; 60: 996-1002.
3. Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M. Close association of HLA-Bw51 with Behcet's disease. Arch Ophthalmol 1982; 100: 1455-1458.
4. Piga M, Mathieu A. Genetic susceptibility to Behcet's disease: role of genes belonging to the MHC region. Rheumatology (Oxford) 2011; 50: 299-310.
5. Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR. Behcet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 1999; 54: 213-220.
6. Durrani K, Papaliodis GN. The genetics of Adamantiades-Behcet's disease. Semin Ophthalmol 2008; 23: 73-79.
7. Horie Y, Meguro A, Ota M, Kitaichi N, Katsuyama Y, Takemoto Y et al. Association of TLR4 polymorphisms with Behcet's disease in a Korean population. Rheumatology (Oxford) 2009; 48: 638-642.
8. Meguro A, Inoko H, Ota M, Katsuyama Y, Oka A, Okada E et al. Genetics of Behcet disease inside and outside the MHC. Ann Rheum Dis 2010; 69: 747-754.
9. Mizuki N, Meguro A, Ota M, Ohno S, Shiota T, Kawagoe T et al. Genomewide association studies identify IL23R-IL12RB2 and IL10 as Behcet's disease susceptibility loci. Nat Genet 2010; 42: 703-706.
10. Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease. Nat Genet 2010; 42: 698-702.
11. Bilguvar K, Ozturk AK, Louvi A, Kwan KY, Choi M, Tatli B et al. Wholeexome sequencing identifies recessive WDR62 mutations in severe brain malformations. Nature 2010; 467: 207-210.
12. Chou LS, Liu CS, Boese B, Zhang X, Mao R. DNA sequence capture and enrichment by microarray followed by next-generation sequencing for targeted resequencing: neurofibromatosis type 1 gene as a model. Clin Chem 2010; 56: 62-72.
13. Shearer AE, DeLuca AP, Hildebrand MS, Taylor KR, Gurrola J 2nd, Scherer S et al. Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing. Proc Natl Acad Sci USA 2010; 107: 21104-21109.
14. Lim BC, Lee S, Shin JY, Kim JI, Hwang H, Kim KJ et al. Genetic diagnosis of Duchenne and Becker muscular dystrophy using next-generation sequencing technology: comprehensive mutational search in a single platform. J Med Genet 2011; 48: 731-736.
15. Johansen CT, Wang J, McIntyre AD, Martins RA, Ban MR, Lanktree MB et al. Excess of rare variants in non-genome-wide association study candidate genes in patients with hypertriglyceridemia. Circ Cardiovasc Genet 2012; 5: 66-72.
16. Lee S, Paik SH, Kim HJ, Ryu HH, Cha S, Jo SJ et al. Exomic sequencing of immune-related genes reveals novel candidate variants associated with alopecia universalis. PLoS One 2013; 8: e53613.
17. Suzuki Kurokawa M, Suzuki N. Behcet's disease. Clin Exp Med 2004; 4: 10-20.
18. Wu TD, Nacu S. Fast and SNP-tolerant detection of complex variants and splicing in short reads. Bioinformatics 2010; 26: 873-881.
19. Kim JI, Ju YS, Park H, Kim S, Lee S, Yi JH et al. A highly annotated whole-genome sequence of a Korean individual. Nature 2009; 460: 1011-1015.
20. Ju YS, Kim JI, Kim S, Hong D, Park H, Shin JY et al. Extensive genomic and transcriptional diversity identified through massively parallel DNA and RNA sequencing of eighteen Korean individuals. Nat Genet 2011; 43: 745-752.
21. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding nonsynonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009; 4: 1073-1081.
22. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P et al. A method and server for predicting damaging missense mutations. Nat Methods 2010; 7: 248-249.
23. Aksu K, Kitapcioglu G, Keser G, Berdeli A, Karabulut G, Kobak S et al. FcgammaRIIa, IIIa and IIIb gene polymorphisms in Behcet's disease: do they have any clinical implications? Clin Exp Rheumatol 2008; 26 (4 Suppl 50), S77-S83.
24. Ben Dhifallah I, Karray EF, Sassi F, Hamzaoui K. Intercellular adhesion molecule 1 K469E gene polymorphism is associated with presence of skin lesions in Tunisian Behcet's disease patients. Tissue Antigens 2010; 75: 74-78.
25. Kim EH, Mok JW, Bang D, Lee ES, Lee S, Park KS. The ICAM1469 E is associated with susceptibility to ocular lesions and vasculitis in Korean patients with Behcet's disease. Adv Exp Med Biol 2003; 528: 235-236.
26. Saadat M. Association between K469E polymorphism of intracellular adhesion molecules-1 ICAM-1 and Behcet's disease. Saudi Med J 2006; 27: 1934.
27. Trundley AE, Hiby SE, Chang C, Sharkey AM, Santourlidis S, Uhrberg M et al. Molecular characterization of KIR3DL3. Immunogenetics 2006; 57: 904-916.
28. Cooper MA, Fehniger TA, Turner SC, Chen KS, Ghaheri BA, Ghayur T et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 2001; 97: 3146-3151.
29. Suzuki Y, Hoshi K, Matsuda T, Mizushima Y. Increased peripheral blood gamma delta\+ T cells and natural killer cells in Behcet's disease. J Rheumatol 1992; 19: 588-592.
30. Yu HG, Lee DS, Seo JM, Ahn JK, Yu YS, Lee WJ et al. The number of CD8\+ T cells and NKT cells increases in the aqueous humor of patients with Behcet's uveitis. Clin Exp Immunol 2004; 137: 437-443.
31. Ahn JK, Chung H, Lee DS, Yu YS, Yu HG. CD8brightCD56\+ T cells are cytotoxic effectors in patients with active Behcet's uveitis. J Immunol 2005; 175: 6133-6142.
32. Yamaguchi Y, Takahashi H, Satoh T, Okazaki Y, Mizuki N, Takahashi K et al. Natural killer cells control a T-helper 1 response in patients with Behcet's disease. Arthritis Res Ther 2010; 12: R80.
33. Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 2001; 22: 195-201.
34. Cahill M, Karabatzaki M, Meleady R, Refsum H, Ueland P, Shields D et al. Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease. Br J Ophthalmol 2000; 84: 154-157.
35. Er H, Evereklioglu C, Cumurcu T, Turkoz Y, Ozerol E, Sahin K et al. Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behcet's disease. Br J Ophthalmol 2002; 86: 653-657.
36. Ozkul Y, Evereklioglu C, Borlu M, Taheri S, Calis M, Dundar M et al. 5,10-Methylenetetrahydrofolate reductase C677T gene polymorphism in Behcet's patients with or without ocular involvement. Br J Ophthalmol 2005; 89: 1634-1637.
37. Mizuki N, Ota M, Kimura M, Ohno S, Ando H, Katsuyama Y et al. Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behcet disease. Proc Natl Acad Sci USA 1997; 94: 1298-1303.
38. Yabuki K, Mizuki N, Ota M, Katsuyama Y, Palimeris G, Stavropoulos C et al. Association of MICA gene and HLA-B 5101 with Behcet's disease in Greece. Invest Ophthalmol Vis Sci 1999; 40: 1921-1926.
39. Park SH, Park KS, Seo YI, Min DJ, Kim WU, Kim TG et al. Association of MICA polymorphism with HLA-B51 and disease severity in Korean patients with Behcet's disease. J Korean Med Sci 2002; 17: 366-370.
40. Liu X, Yang P, Wang C, Li F, Kijlstra A. IFN-alpha blocks IL-17 production by peripheral blood mononuclear cells in Behcet's disease. Rheumatology (Oxford) 2011; 50: 293-298.